**Author details**

Dablu Lal Gupta<sup>1</sup> \*, Tejparkash Sinha<sup>2</sup> , Sanjeev Bhoi<sup>2</sup> and D.N. Rao<sup>3</sup>

\*Address all correspondence to: dablugupta10@gmail.com

1 Institute of Science, Nirma University, Ahmedabad, Gujarat, India

2 Department of Emergency Medicine, JPN Apex Trauma Center, All India Institute of Medical Sciences, New Delhi, India

3 Department of Biochemistry, All India Institute of Medical Science, New Delhi, India

### **References**


[4] Spence RT, Scott JW, Haider A, Navsaria PH, Nicol AJ. Comparative assessment of inhospital trauma mortality at a South African trauma center and matched patients treated in the United States. Surgery. 2017;**162**(3):620-627

**5. Conclusion**

48 Infectious Process and Sepsis

**Acknowledgements**

Arul Selvi is acknowledged.

The authors have no conflicts of interest.

Medical Sciences, New Delhi, India

\*, Tejparkash Sinha<sup>2</sup>

\*Address all correspondence to: dablugupta10@gmail.com

Reviews. Immunology. Oct. 2008;**8**(10):776-787

Danish Medical Journal. Oct. 2014;**61**(10):A4928

Journal of Emergency Nursing. Jul. 2014;**40**(4):405-406

1 Institute of Science, Nirma University, Ahmedabad, Gujarat, India

2 Department of Emergency Medicine, JPN Apex Trauma Center, All India Institute of

3 Department of Biochemistry, All India Institute of Medical Science, New Delhi, India

[1] Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nature

[2] Moore K. Trauma mortality: Understanding mortality distribution to improve outcomes.

[3] Mikkelsen R, Møller Hansen O, Brink O. Non-survivors after admission to trauma Centre.

**Conflict of interest**

**Author details**

Dablu Lal Gupta<sup>1</sup>

**References**

The purpose of this chapter is to bring together currently available information of cytokine gene polymorphisms in pro-inflammatory and anti-inflammatory cytokine genes in the development of various complications such as sepsis, septic shock, and MODS in trauma patients. Specific emphasis is placed on the polymorphism of those cytokines which potentially contributed to the development of these complications and correlates with unfavorable outcomes.

This work was funded through the Indian Council of Medical Research (ICMR), New Delhi. The author is thankful to the University Grant Commission (UGC), New Delhi, India, for fellowship assistance. The excellent scientific assistance of Dr. Vinay, Dr. Amit Gupta, and Dr.

, Sanjeev Bhoi<sup>2</sup> and D.N. Rao<sup>3</sup>


[21] Bauer I et al. Influence of gender on stimulated cytokine response in patients with severe sepsis. Anaesthesist. May 2006;**55**(5):515-527

[35] Wu H, Guo J, He Y, Yin H, Shu J. Relationship between IL-10 gene -819C/T polymorphism and the risk of inflammatory bowel disease: A meta-analysis. African Health Sciences.

Cytokine Gene Polymorphism and Sepsis http://dx.doi.org/10.5772/intechopen.90572 51

[36] Sharma N, Toor D. Interleukin-10: Role in increasing susceptibility and pathogenesis of

[37] Wattanathum A, Manocha S, Groshaus H, Russell JA, Walley KR. Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest. Sep. 2005;**128**(3):1690-1698 [38] Jeremić V, Alempijević T, Mijatović S, Arsenijević V, Ladjevic N, Krstić S. Clinical relevance of IL-10 gene polymorphism in patients with major trauma. Medicinski glasnik (Zenica).

[39] Liese AM, Siddiqi MQ, Siegel JH, Deitch EA, Spolarics Z. Attenuated monocyte IL-10 production in glucose-6-phosphate dehydrogenase-deficient trauma patients. Shock. Jul.

[40] Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: Back to the future.

[41] Zhang A-Q et al. Associations between interleukin-1 gene polymorphisms and sepsis risk:

[42] Wen A-Q et al. Clinical relevance of IL-1β promoter polymorphisms (1470, 511, and

[43] Raza Y et al. Combination of interleukin 1 polymorphism and *Helicobacter pylori* infection: An increased risk of gastric cancer in Pakistani population. Pathology Oncology Research.

[44] Fontanella M et al. Interleukin-1 cluster gene polymorphisms and aneurysmal subarach-

rheumatic fever/rheumatic heart disease. Cytokine. 2017;**90**:169-176

Sep. 2016;**16**(3):866-872

Aug. 2014;**11**(2):326-332

Oct. 2017;**23**(4):873-880

Immunity. Dec. 2013;**39**(6):1003-1018

A meta-analysis. BMC Medical Genetics. Jan. 2014;**15**:8

noid hemorrhage. Neurosurgery. Jun. 2010;**66**(6):1058-1063

31) IN patients with major trauma. Shock. Jun. 2010;**33**(6):576-582

2002;**18**(1):18-23


[35] Wu H, Guo J, He Y, Yin H, Shu J. Relationship between IL-10 gene -819C/T polymorphism and the risk of inflammatory bowel disease: A meta-analysis. African Health Sciences. Sep. 2016;**16**(3):866-872

[21] Bauer I et al. Influence of gender on stimulated cytokine response in patients with severe

[22] Bidwell J et al. Cytokine gene polymorphism in human disease: On-line databases. Genes

[23] Gordon AC et al. TNF and TNFR polymorphisms in severe sepsis and septic shock: A

[24] Azevedo ZM et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: Importance in ARDS in septic pediatric critically ill patients.

[25] Ceylan E, Karkucak M, Coban H, Karadag M, Yakut T. Evaluation of TNF-alpha gene (G308A) and MBL2 gene codon 54 polymorphisms in Turkish patients with tuberculosis.

[26] Huangfu F, Zhao X, Wang X, Tang L, Jiang J. There is no association between TNF-α gene polymorphisms and the risk of coronary artery heart disease: A meta-analysis. The Jour-

[27] Tu Y, Fan G, Zeng T, Cai X, Kong W. Association of TNF-α promoter polymorphism and Graves' disease: An updated systematic review and meta-analysis. Bioscience Reports.

[28] Akbulut UE, Çebi AH, Sağ E, İkbal M, Çakır M. Interleukin-6 and interleukin-17 gene polymorphism association with celiac disease in children. The Turkish Journal of Gastro-

[29] Bashashati M, Moradi M, Sarosiek I. Interleukin-6 in irritable bowel syndrome: A systematic review and meta-analysis of IL-6 (-G174C) and circulating IL-6 levels. Cytokine. 2017;

[30] Zhai K, Yang Y, Gao Z-G, Ding J. Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer. Oncotarget. Jul. 2017;**8**(27):44490-44497

[31] Hu S et al. Association between IL-6-174G/C polymorphism and risk of multiple sclerosis: A meta-analysis. Genetic Testing and Molecular Biomarkers. Feb. 2014;**18**(2):127-130

[32] Jeremić V et al. Clinical relevance of IL-6 gene polymorphism in severely injured patients.

[33] Sapan HB et al. Pattern of cytokine (IL-6 and IL-10) level as inflammation and antiinflammation mediator of multiple organ dysfunction syndrome (MODS) in polytrauma.

[34] Gupta DL, Nagar PK, Kamal VK, Bhoi S, Rao DN. Clinical relevance of single nucleotide polymorphisms within the 13 cytokine genes in north Indian trauma hemorrhagic shock patients. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. Nov.

Bosnian Journal of Basic Medical Sciences. 2014;**14**(2):110-117

International Journal of Burns and Trauma. 2016;**6**(2):37-43

prospective multicentre study. Genes and Immunity. Dec. 2004;**5**(8):631-640

sepsis. Anaesthesist. May 2006;**55**(5):515-527

Human Immunology. Jun. 2012;**73**(6):661-667

Journal of Infection and Public Health. Dec. 2017;**10**(6):774-777

nal of Cardiovascular Surgery. Oct. 2017;**58**(5):770-778

and Immunity. Sep. 1999;**1**(1):3-19

50 Infectious Process and Sepsis

2018;**38**(2):27

**99**:132-138

2015;**23**:96

enterology. Nov. 2017;**28**(6):471-475


**Chapter 5**

**Provisional chapter**

**Hemostatic Aspect of Sepsis**

**Hemostatic Aspect of Sepsis**

Bashir Abdrhman Bashir Mohammed

Bashir Abdrhman Bashir Mohammed

http://dx.doi.org/10.5772/intechopen.90800

**Abstract**

cure from sepsis.

**1. Introduction**

Additional information is available at the end of the chapter

Additional information is available at the end of the chapter

DOI: 10.5772/intechopen.90800

The hemostatic system is composed of primary hemostasis and coagulation on the one hand, and natural regulatory anticoagulant protein mechanisms and fibrinolysis, on the other hand. Under physiological conditions, these processes are balanced. Under septic conditions, coagulopathy may followed by disseminated intravascular coagulation (DIC). Tissue factor (TF) pathway is regarded to be the core way for activation of the coagulation cascade in sepsis. TF is triggered by pro-inflammatory mediators, encompassing cytokines, C-reactive protein, and advanced glycation end products in peripheral blood cells and on microparticle molecules. Once a septic patient develops DIC, a significant increase in the susceptibility of developing organ dysfunction, morbidity, and mortality may occur. This work was basic elucidation of the idea that coagulation and its inhibitors are of major importance in coagulation-inflammation noise, similarly as in

**Keywords:** coagulopathy, diagnostic criteria, inflammation, DIC, infection, sepsis

Sepsis is a confounding clinical condition that emerges when a patient responds unfavorably to a disease and creates organ dysfunction as an outcome. It can influences all the intents and purposes of organ framework; however, organ involvement and the level of dysfunction will change remarkably between patients. It will end in death in extreme cases. Sepsis is these days formally distinct as a dysregulated host reflection to disease, triggering perilous organ pathology [1]. This new definition, working with clinical measures, will ideally give a lot of grounded, increasingly predictable base to better illuminate occurrence, results, and survey. The impact of sepsis is implausibly florid, and therefore the infectious track will vary significantly among patients. So far, sepsis has not been resolved and determined crucially in several cases.

> © 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,

distribution, and reproduction in any medium, provided the original work is properly cited.

### **Chapter 5 Provisional chapter**

### **Hemostatic Aspect of Sepsis Hemostatic Aspect of Sepsis**

Bashir Abdrhman Bashir Mohammed Bashir Abdrhman Bashir Mohammed

Additional information is available at the end of the chapter Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/intechopen.90800

**Abstract**

The hemostatic system is composed of primary hemostasis and coagulation on the one hand, and natural regulatory anticoagulant protein mechanisms and fibrinolysis, on the other hand. Under physiological conditions, these processes are balanced. Under septic conditions, coagulopathy may followed by disseminated intravascular coagulation (DIC). Tissue factor (TF) pathway is regarded to be the core way for activation of the coagulation cascade in sepsis. TF is triggered by pro-inflammatory mediators, encompassing cytokines, C-reactive protein, and advanced glycation end products in peripheral blood cells and on microparticle molecules. Once a septic patient develops DIC, a significant increase in the susceptibility of developing organ dysfunction, morbidity, and mortality may occur. This work was basic elucidation of the idea that coagulation and its inhibitors are of major importance in coagulation-inflammation noise, similarly as in cure from sepsis.

DOI: 10.5772/intechopen.90800

**Keywords:** coagulopathy, diagnostic criteria, inflammation, DIC, infection, sepsis

### **1. Introduction**

Sepsis is a confounding clinical condition that emerges when a patient responds unfavorably to a disease and creates organ dysfunction as an outcome. It can influences all the intents and purposes of organ framework; however, organ involvement and the level of dysfunction will change remarkably between patients. It will end in death in extreme cases. Sepsis is these days formally distinct as a dysregulated host reflection to disease, triggering perilous organ pathology [1]. This new definition, working with clinical measures, will ideally give a lot of grounded, increasingly predictable base to better illuminate occurrence, results, and survey. The impact of sepsis is implausibly florid, and therefore the infectious track will vary significantly among patients. So far, sepsis has not been resolved and determined crucially in several cases.

© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. © 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Determination often depends upon the practician pattern as authoritative microbiological proof of Associate in Nursing encouraging contamination is frequently missing. Besides, endeavors to find an association in nursing enchantment remedy and sepsis have been in vain [2].

Septic patients and intensive cases of DIC might evidence thromboembolic involvements or clinically less clear microvascular clot development, which will boost multiple organ failure [6, 8]. In several cases, intensive hemorrhage may well be the predominant presentation [9]; also, a lot of the time, sepsis and a DIC cause synchronous thrombosis and bleeding. Hemorrhage is owed to consumption and consequent depletion of coagulation factors and platelets, brought by progressing activation of the hemostatic system [10]. Furthermore, this conjunction might present because the Waterhouse-Friderichsen syndrome, unremarkably highlighted throughout fulminant meningococcal septicemia, and despite numerous differ-

Clinically vital hemostatic changes might happen in up to 70% of septic patients. Furthermore, concerning 35% of patients with sepsis can fulfill the standard criteria for DIC [12, 13]. Most

Usually, blood thrombocyte count reduces within the initial 4 days following admission to the emergency clinic [16]. The seriousness of sepsis relates uniquely to the decline in platelet count [17]. Basic causes of thrombocytopenia in sepsis are diminished platelet production, upgraded consumption, or sequestration in the spleen. Diminished generation of megakaryocytes in the bone marrow may appear to be indiscernible with the elevated levels of platelet production-stimulating pro-inflammatory mediators, for instance, tumor necrosis factor (TNF)-α and interleukin (IL)-6, and raised values of thrombopoietin in patients with sepsis, which presumptively ought to trigger megakaryopoiesis [18]. However, in a very sizable proportion of septic patients, hemophagocytosis happens, involving dynamic phagocytosis of thrombocyte progenitors and other diverse hematopoietic cells by mononuclear cells, clearly fetching by raising the concentration of macrophage stimulating factor (M-CSF) in sepsis [19]. Thrombocyte utilization is outwardly likewise critical in sepsis, due to thrombocyte activa-

Platelet activation, excessive utilization, and devastation occur at the endothelial surface because of the rule of endothelial cell-platelet interplay in sepsis, even though the degree may differ between completely different vascular beds of assorted organs [20]. Elongation time of hemostatic analyses, like prothrombin clotting time (PT) or the kaolin-cephalin clotting time (KCCT), is noticeable in 15–30% of septic patients [21]. Hemostatic changes involve high fibrin split products items (in quite 95% of patients) [22, 23] and scanty values of natural regulatory anticoagulant proteins, for instance, anti-thrombin and protein C (90%

In the recent three decades, the tracks engaged in hemostatic disorder of sepsis are explained for a significant part [7]. Unmistakably different components in the coagulation system act

/l) [14, 15].

Hemostatic Aspect of Sepsis

55

http://dx.doi.org/10.5772/intechopen.90800

ent microorganisms may cause this clinical circumstance [11].

tion optional to ongoing advancement of thrombin.

**4. Tracks prompting coagulation adjustments in sepsis**

of septic patients) [23, 24].

**3. Recurrence of clinically relevant coagulopathy in sepsis**

septic patients can create thrombocytopenia (platelet count less than 150 × 10<sup>9</sup>

Management is primarily supported with resuscitation, organ backup and wipe out the dependent contagion with antibiotics ± supply control [2]. On an increasingly affirmative note, our comprehension of sepsis has significantly amplified, and superior diagnostics are being created to help recognizable proof and focus on the potion and timing of restorative medications. In developing nations, sepsis has a consolidated recurrence of 2.5 million patients for each year and demise extent of roughly 650,000 patients consistently [3]. This would mean, usually 19 million instances of sepsis a year, internationally, with roughly 5 million deaths [3]. This estimation is probably going to be uncontrollably inaccurate, as there is a general absence of intensive medical specialty data on low- and middle-income countries. The absence of good essential consideration, sufficient infection control, convenient anti-microbial treatment, poor staffing levels, and satisfactory basic care arrangement represents a totally distinctive circumstance in these nations. The World Health Organization gives extra insight regarding this problem. As indicated by WHO data, three irresistible infections were among the 10 most important reasons for death worldwide in 2015: lower respiratory disorder, diarrheal disease, and tuberculosis with a consolidated mortality of 7.3 million individuals [4].

Most of those fatalities happen in developing countries. Similarly, most die from sepsis as infection, while not organ dysfunction cannot be touch-and-go. The death rate of sepsis is declining within the developing countries, to some extent due to the very fact that of previous acknowledgment and clinical administration nevertheless additionally on the grounds that expanded acknowledgment has considerably expanded the denominator [5]. Sepsis might not usually be recorded because the reason for death may be attributed of various comorbidities, as an example, cancer or cardiovascular issues. Death in a septic patient may be connected to a secondary or an unrelated sequel [6].
